Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (261-270 of 338) with videos related to

Pageof 34
Sort By:
Molecular Cancer|August 14, 2010
Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in ratMeng Fang, Sylviane Dewaele, Yun-Peng Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2016
Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected CasesJong-Mu Sun, Wei Zhou, Yoon-La Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2013
A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumorsSilvia Park, Myung-ju Ahn, Jin Seok Ahn, et al.
Journal of Korean Neurosurgical Society|December 3, 2020
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife RadiosurgeryMin Ho Lee, Kyung-Rae Cho, Jung Won Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2015
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerSun Min Lim, Woong Youn Chung, Kee-Hyun Nam, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapyByung Jo Park, Jong Ho Cho, Jung Hee Lee, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancerHyun Ae Jung, Jinyeong Lim, Yoon-La Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or ErlotinibJi Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Pageof 34

Showing results (261-270 of 338) with videos related to

Sort By:
Pageof 34
Molecular Cancer|August 14, 2010
Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in ratMeng Fang, Sylviane Dewaele, Yun-Peng Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2016
Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected CasesJong-Mu Sun, Wei Zhou, Yoon-La Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2013
A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumorsSilvia Park, Myung-ju Ahn, Jin Seok Ahn, et al.
Journal of Korean Neurosurgical Society|December 3, 2020
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife RadiosurgeryMin Ho Lee, Kyung-Rae Cho, Jung Won Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2015
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerSun Min Lim, Woong Youn Chung, Kee-Hyun Nam, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapyByung Jo Park, Jong Ho Cho, Jung Hee Lee, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancerHyun Ae Jung, Jinyeong Lim, Yoon-La Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or ErlotinibJi Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Pageof 34